ProfileGDS5678 / 1441222_x_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 16% 15% 16% 15% 15% 16% 18% 15% 15% 15% 16% 15% 15% 15% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.4186716
GSM967853U87-EV human glioblastoma xenograft - Control 22.3756715
GSM967854U87-EV human glioblastoma xenograft - Control 32.3872716
GSM967855U87-EV human glioblastoma xenograft - Control 42.3180715
GSM967856U87-EV human glioblastoma xenograft - Control 52.3238215
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.4581816
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.4698618
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.3591215
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.3439515
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.3696515
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.3722716
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.3414415
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.3761215
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.3693715